Abenza
Abenza announces investment in bioconjugation and ADC capabilities
March 28, 2024Business Services ADC, Abenza, Pharmacy, bioconjugation, investment
Abenza has announced a major investment in bioconjugation and antibody drug conjugate (ADC) capabilities in response to an increasing industry …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
